-
1
The study analyzed 234 cases of Parkinson's disease with depression, ultimately including 190 patients for treatment evaluation.
-
2
Patients were divided into two groups: one receiving transcranial magnetic stimulation (TMS) and the other receiving TMS combined with virtual reality (VR).
-
3
Significant improvements in depression, anxiety, cognitive function, and motor performance were observed in both treatment groups after intervention.
-
4
The TMS + VR group showed more pronounced improvements in clinical scores compared to the TMS-only group, with all changes statistically significant.
-
5
No significant differences in adverse effects were reported between the TMS and TMS + VR treatment groups, indicating comparable safety.
